COR Therapeutics ripe for buyout - Business Week
biz.yahoo.com
McCormant thinks that COR...
heheh
*OT*
Hey McCamant--how about loading up on that
CytoTherapeutics when your CORR stock gets
to $20--geeze, I'm really suffering down
here with things that end in "ii". ctii,
ntii--somebody stop me before I get hurt!
Somebody was kind enough to PM this to me,
it's a month stale now:
Expect to see a partnership announced by
CTII in the not too distant future. CTII is a
buy under $2.
Then ctii must be a steal at a buck--
too bad I'm the only buyer down here.
Oh, don't get me wrong, I'm routing for CORR and
CEPH, and IMCL...and the others, trouble is,
when I thought I was getting a good bang for
the buck in this nano cap stuff, I didn't realize
I was the one going to get shot;-)
But you get what you pay for--and I never did
subscribe to MSTL, or biotechnav (except for
the three month trial) or NeuroInvestment.
And now it's time to hunker down in cash and
gold as the market craps out, so sad, the
market's really never let a lot of money slosh
on over into the biotechs, oh well. And now
I've become attatched to the biotech stocks
I own, dang it was not supposed to go this way.
(sorry friends of CORR, sometimes I just get
on a rant, and cannot stop myself--McCamant's
picks have not been so bad, but it just so
happens that the one he mentioned that I was
attracted to has been a real stinker...this
seemed like a good place ant time to vent my
frustration). |
